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The redox transformations and nucleophilic 
replacements as possible metabolic reactions 
of the drug “Triazaverin”. The chemical 
modeling of the metabolic processes
As a model of metabolic transformations of antiviral drug “Triazaverin” and 
its analogues-2-alkylthio-6-nitro-1,2,4-triazolo[5,1-c][1,2,4]triazine-7-ones 
1a-d examined the oxidation of alkylthio groups to the corresponding sulfox-
ides 2a-d and sulfones 3a-d, as well as the process of nucleophilic substitution 
sulfonyloxy group of cysteine and cysteamine with the formation of compounds 
5 and 6.
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introduction
The relevance of creating new 
antiviral drugs due to the joint action of 
such operating factors as the spread of so-
cially significant, particularly dangerous 
infections, and the emergence of patho-
genic viral strains resistant to existing 
drugs.
The antiviral drug “Triazaverin” and 
its analogues are highly effective in ex-
periments in vivo and decreased activity 
in experiments on cell cultures, suggest-
ing that the antiviral effect is not the “Tri-
azaverin”, and products of its transforma-
tions in the body. One way to identify 
such transformations in the organism is 
to predict the possible products of modi-
fications of the compounds and chemical 
synthesis models.
Based on the molecular structure 
of compounds 1a and study of chemi-
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cal properties of nitroazolo[5,1-c][1,2,4]
triazines [1] can assume various variants 
of metabolism: redox transformations in 
the body (directions A, B) as the reduc-
tion of the nitro group under the action 
of a reductases (direction A), oxidation 
of alkylthio fragment under the action 
of oxidases (direction B) and its further 
transformation. The part transferases un-
der the action of N  – and S-nucleophils, 
such as lysine, arginine, cysteine could 
lead to the replacement of alkylthio- or 
nitro groups (directions C, D).
The hydrolytic enzymes are also quite 
capable to lead the transformation of “Tri-
azaverin” accompanying the degradation 
of triazine cycle with the break of bond 
C-N (direction E). The alkylation on the 
N-atom is possible too (direction F).
With regard to the redox transforma-
tions of “Triazaverin” that we previously 
established that after the intragastric 
administration of laboratory animals of 
the drug substance, there is a reduction 
of the nitro group with the formation of 
2-methylthio-6-amino-1,2,4-triazolo[5,1-
c][1,2,4]triazine-7-one [2], does not ex-
hibit antiviral action in vitro and, most 
likely, which is not applicable metabolite.
Results and Discussion
Considering the possibility of oxida-
tion of alkylthio groups under use “Triaza-
verin” and its analogues, it should be noted 
that in the majority of viral infections at 
an early stage of the process is increased 
generation of reactive oxygen species [3]. 
Based on the foregoing, it is natural to as-
sume that in these conditions can occur in 
the oxidation reaction of S-methyl group 
of “Triazaverin” characteristic, for example, 
for SH-containing amino acids of methio-
nine under oxidative stress.
In the present communication present 
data on the production model experi-
ments with the drug “Triazaverin”  – the 
study of the oxidation of S-methyl group 
and the behavior of oxidation products 
under the action of S-nucleophils. This 
approach allows, on the one hand, to pre-
dict the course of chemical reactions relat-
ed to the behavior of the drug in the body, 
and on the other hand, by the synthesis of 
the respective compounds to simulate the 
process of formation of covalent bonds 
of azolo[5,1-c]1,2,4-triazines with S-key 
fragments of proteins as cells and virus.
Redox-transformations of “Triazaverin” and its derivatives
The first aspect of this work was the 
synthesis of model compounds  – oxida-
tion of sulfhydryl groups in molecules of 
sodium salts of 2-alkylthio-6-nitro-1,2,4-
triazolo[5,1-c]1,2,4-triazine-7-ones 1a-d 
or in the associated N-H-acids compris-
ing the formation of heterocyclic sulfox-
ides 3a-d and sulfones 4a-d. Sulfoxides 
Scheme 1
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3a-d (Scheme 1) were obtained under the 
treatment of the compounds 1a-d or 2a-d 
by the equimolar quantity of 18 % hydro-
gen peroxide in the trifluoroacetic acid.
Further oxidation to the correspond-
ing sulfones 4a-d with the yields 62–71 % 
carried out by gradual addition of excess 
2.2 equivalent of 30 % hydrogen peroxide 
to the suspension of 2-alkylthio-1,2,4-
triazolo[5,1-c]-triazines in the trifluoro-
acetic acid at room temperature.
The represented reactions model the 
possible metabolic transformations of 
“Triazaverin” and its derivatives under the 
action of the active forms of oxygen in-
cluding hydrogen peroxide.
Nucleophilic replacement of methyl-
sulfonilic group. It is known that alkyl-
sulfonyl fragments are susceptible to the 
substitution reactions when interacting 
with nucleophiles [4]. With regard to the 
behavior of nitro group in “Triazaverin” 
but the susceptibility of the nitro group 
associated with aromatic (heteroaromat-
ic) cycle to the displacement under the 
nucleophiles [5] is well known.
Thus in the structure of 2-alkylsul-
fonyl-1,2,4-triazolo[5,1-c]1,2,4-tria-
zine-7-ones 4a-d there are two groups that 
are susceptible to nucleophilic displace-
ment. This situation is of interest for the 
research of the comparative reactive abil-
ity of the easy outgoing groups CH3SO2-
in 1,2,4-triazole and NO2 in1,2,4-triazine 
cycles in the compounds 4a-d and also 
as the model of the behavior of “Triaza-
verin” in the organism. As the nucleo-
philic reagents in this work were used 
S-nucleophiles(cysteine and cysteamine), 
which can be regarded as models of pro-
tein fragments containing cysteine frag-
ment.
The substitution sulfonylic fragment 
in 2-methylsulfonyl-1,2,4-triazolo[5,1-
c]1,2,4-triazine 4a under the influence, 
as cysteine and cysteamine, occurs in dry 
methanol in the presence of triethylamine 
in a few days with the formation of com-
pounds 5 and 6- substitution products 
methylsulfonyl group with the yields 41–
46 % (Scheme 2).
The date of NMR 1H, IR-spectrosco-
py and elemental analysis for the com-
pounds 5, 6 correspond to the attributed 
structures.
The described displacement of alkyl- 
sulfonyl group in the compound 4a is 
the argument in favor of the assumption 
about the possible participation of this 
fragment in the metabolic transforma-
tions of “Triazaverin”.
Experiment part
NMR1H and 13C spectra were record-
ed on a spectrometer Bruker DRX-400 
(400 and 100 MHz, respectively) in 
DMSO-d6 and D2O. The chemical shifts 
are recorded in σ scale relatively inter-
nal standard TMS for NMR1H spectra. 
Elemental analyses were performed on 
CHNS-analyzer “Perkin Elmer 2400-II”. 
IR spectra (4000–400 cm–1) of the re-
ceived compounds were recorded on 
a spectrophotometer “Perkin Elmer 
Spectrum One BFTIR” in thin layer of a 
Scheme 2
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sample (DRA). Reaction monitoring and 
the individuality of the synthesized com-
pounds was performed by TLC plates 
Sorbfil in the systems: ethyl acetate and 
butanol-acetic acid-water 4:1:1.
General methods 1 for preparation of 
2-alkylsulfinyl-6-nitro-1,2,4-triazolo[5,1-
c]1,2,4-triazin-7-ones (3a-d).
To a suspension 0.01 mol of so-
dium salt 2-alkylthio-6-nitro-1,2,4-
triazolo[5,1-c]1,2,4-triazin-7-one (1) in 
10 mL of trifluoroacetic acid by mixing 
was added 1.78 ml (1 eq.) of 18 % hydro-
gen peroxide. The reaction mass is mixed 
at room temperature during 3 hours. The 
resulting solid precipitate was filtered and 
was crystallized from iso-propanol.
2 - M e t h y l s u l f i n y l - 6 - n i t r o - 1 , 2 , 4 -
triazolo[5,1-c]1,2,4-triazine-7-one (3a) 
was obtained on the general methods 
1 from compound 1a in terms of beige 
crystalline solid, yield 70 %, mp 256 °C, 
1H NMR (DMSO-d6, 400 MHz): 9.84 
(1H, уш.с., NH), 3.05 (3Н, с, CH3); 13C 
NMR (DMSO-d6, 100 MHz): 169.09 (C2), 
157.32 (C3a), 144.05 (C7), 143.57 (C6), 
25.58 (СН3SO); IR (ν/sm-1): 1750 (С=O); 
1036 (–SO-); 1553,1340 (NO2); elemen-
tal analysis, calculated for С5H4N6O4S %: 
С  24.59, H 1.65, N 34.42. Found, %: C 
24.62, H 1.43, N 34.28.
2 - E t h y l s u l f i n y l - 6 - n i t r o - 1 , 2 , 4 -
triazolo[5,1-c]1,2,4-triazine-7-one (3b) 
was obtained on the general methods 1 
from compound 1b in terms of beige crys-
talline solid. Yield 74 %, mp 227 °C, 1H 
NMR (DMSO-d6, 400 MHz): 11.16 (1H, 
br.s., NH), 3.36–3.16 (2Н, m, СН2), 1.24 
(3H, t, J = 7.4, CH3); 13C NMR (DMSO-
d6, 100 MHz): 168.34 (C2), 157.58 (C3a), 
144.36 (C7), 143.87 (C6), 46.64 (CH2SO), 
6.15 (СН3); IR (ν/sm-1): 1748 (С=O); 
1022 (–SO-); 1552, 1336 (NO2); elemen-
tal analysis, calculated for С6H6N6O4S, 
%: С  27.91, H 2.34, N 32.55. Found, %: 
C 27.87, H 2.27, N 32.31.
2 - P r o p y l s u l f i n y l - 6 - n i t r o - 1 , 2 , 4 -
triazolo[5,1-c]1,2,4-triazine-7-one (3c) 
was obtained on the general methods 
1 from compound 1c in terms of beige 
crystalline solid. Yield 72 %, mp 222 °C, 
1H NMR (DMSO-d6, 400 MHz): 8.41 (1H, 
br.s., NH), 3.29–3.18 (2Н, m, SOCH2), 
1.78–1.55 (2Н, m, СН2), 1.01 (3H, t, J = 7.4, 
СН3); 13C NMR (DMSO-d6, 100 MHz): 
168.19 (C2), 157.87 (C3a), 144.19 (C7), 
143.46 (C6), 54.15 (CH2SO), 15.21 (СН2), 
12.94 (СН3); IR (ν/sm-1): 1748 (С=O); 
1013 (–SO-); 1556, 1336 (NO2); elemen-
tal analysis, calculated for С7H8N6O4S, %: 
С  30.88, H 2.96, N 30.87. Found, %: 
C 30.82, H 3.12, N 30.77.
2-iso-Propylsulfinyl-6-nitro-1,2,4-
triazolo[5,1-c]1,2,4-triazine-7-one (3d) 
was obtained on the general methods 
1 from compound 1d in terms of beige 
crystalline solid. Yield 77 %, mp 239 °C, 
1H NMR (DMSO-d6, 400 MHz): 7.60 (1H, 
br.s., NH), 3.49–3.38 (1Н, m, СН), 1.27 
(6H, dd, J = 6.8, 2СН3); 13C NMR (DM-
SO-d6, 100 MHz): 167.79 (C2), 157.42 
(C3a), 144.33 (C7), 143.86 (C6), 53.07 
(CHSO), 15.92 (СН3), 14.59 (СН3); IR (ν/
sm–1): 1752 (С=O); 992(–SO–); 1555, 1342 
(NO2); elemental analysis, calculated for 
С7H8N6O4S, %: С 30.88, H 2.96, N 30.87. 
Found, %: C 31.07, H 2.95, N 30.89.
The general methods 2 for prepara-
tion of 2-alkylsulfonyl-6-nitro-1,2,4-
triazolo[5,1-c]1,2,4-triazin-7-ones (4a-d).
To a suspension 0.01 mol of sodium salt 
2-alkylthio-6-nitro-1,2,4-triazolo[5,1-
c]1,2,4-triazin-7-one (1) in 14 mL of tri-
fluoroacetic acid by mixing dropwise was 
added 4 ml (2 eq.) of 30 % hydrogen per-
oxide in order that a temperature wasn’t 
The redox transformations and nucleophilic replacements as possible 
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above 80 oC. Then the reaction mass was 
mixed at a room temperature during 
3  hours, the precipitate was filtered and 
crystallized from iso-propanol.
2 - M e t h y l c u l f o n y l - 6 - n i t r o 1 , 2 , 4 -
triazolo[5,1-c]1,2,4-triazine-7-one (4a) 
was obtained on the general methods 
2 from compound 1a in terms of beige 
crystalline solid. Yield 66 %, mp 275 °C, 
1H NMR (DMSO-d6, 400 MHz): 7.57 (1H, 
br.s., NH), 3.41 (3Н, s, CH3); 13C NMR 
(DMSO-d6, 100 MHz): 163.86 (C2), 158.41 
(C3a), 144.69 (C7), 143.64 (C6), 41.84 
(СН3SO2); IR (ν/sm-1): 1759 (С=O); 1347, 
1138 (–SO2-); 1570, 1323 (NO2);); elemen-
tal analysis, calculated for С5H4N6O5S, %: 
С  23.08, H 1.55, N 32.30. Found, %: C 
23.21, H 1.31, N 32.33.
2 - E t h y l s u l f o n y l - 6 - n i t r o - 1 , 2 , 4 -
triazolo[5,1-c]1,2,4-triazine-7-one (4b) 
was obtained on the general methods 
2 from compound 1b in terms of beige 
crystalline solid. Yield 64 %, mp 259 °C, 
1H NMR (DMSO-d6, 400 MHz): 9.71 (1H, 
br.s., NH), 3.52 (2H, qv., J = 7.4, СН2), 1.33 
(3H, t, J = 7.4, CH3); 13C NMR (DMSO-
d6, 100 MHz): 162.82 (C2), 158.93 (C3a), 
145.06 (C7), 144.02 (C6), 48.54 (CH2SO2), 
7.25 (СН3); IR (ν/sm-1): 1759 (С=O); 1311, 
1140 (–SO2-); 1557, 1332 (NO2); elemen-
tal analysis, calculated for С6H6N6O5S, %: 
С  26.28, H 2.21, N 30.65. Found, %: C 
26.44, H 2.20, N 30.43.
2 - P r o p y l s u l f o n y l - 6 - n i t r o - 1 , 2 , 4 -
triazolo[5,1-c]1,2,4-triazine-7-one (4c) 
was obtained on the general methods 2 
from compound 1c in terms of beige crys-
talline solid. Yield 71 %, mp 264 °C, 1H 
NMR (DMSO-d6, 400 MHz): 11.98 (1H, 
br.s., NH), 3.53 (2Н, t, J = 7.6, SO2CH2), 
1.76–1.67 (2Н, m, СН2), 0.98 (3H, t, 
J = 7.4, СН3); 13C NMR (DMSO-d6, 
100 MHz): 163.22 (C2), 158.44 (C3a), 
144.91 (C7), 143.99 (C6), 55.35 (CH2SO2), 
16.20 (СН2), 12.94 (СН3); IR (ν/sm–1): 
1748 (С=O); 1293, 1139 (–SO2–); 1556, 
1326 (NO2); elemental analysis, calculat-
ed for С7H8N6O5S, %: С 29.17, H 2.80, N 
29.16. Found, %: C 29.01, H 2.88, N 29.24.
2-iso-Propylsulfinyl-6-nitro-1,2,4-
triazolo[5,1-c]1,2,4-triazine-7-one (4d) 
was obtained on the general methods 
2 from compound 1d in terms of beige 
crystalline solid. Yield 62 %, mp 282 °C, 
1H NMR (DMSO-d6, 400 MHz): 8.27 (1H, 
br.s., NH), 3.73–3.63 (1Н, m, СН), 1.35 
(6H, d, J = 6.8, 2СН3); 13C NMR (DM-
SO-d6, 100 MHz): 161.91 (C2), 158.80 
(C3a), 144.98 (C7), 144.02 (C6), 54.30 
(CHSO2), 15.02 (2СН3); IR (ν/sm-1): 1749 
(С=O); 1311, 1135 (–SO2-); 1556, 1326 
(NO2); elemental analysis, calculated for 
С7H8N6O5S, %: С 29.17, H 2.80, N 29.16. 
Found, %: C 29.11, H 2.69, N 29.00.
The general methods 3 of nucleo-
philic replacement in 2-methylsulfo-
nyl-6-nitro-1,2,4-triazolo[5,1-c]1,2,4-tri-
azin-7-one.
To a suspension 0.001 mol of cyste-
ine (or cysteamine) in 20 ml of methanol 
were added triethylamine and were mixed 
at the argon atmosphere during 5 min, 
then to a reaction mass were added equiv-
alent of 2-alkylsulfonyl-triazolotriazin 
and were refluxed. The end of reaction is 
determined by TLC in system: butanol-
acetic acid-water 4:1:1. The resulting solid 
precipitate was washed with iso-propanol.
Triethylammonium salt of 
(2’-amino-2’-carboethoxyethylthio)-
6-nitro-1,2,4-triazolo[5,1-c]triazine 
hydrochloride (5) was obtained with use 
of the general methods 3 and 3 equivalent 
of triethylamine. The product was crys-
tallized from the water ethanol in terms 
of canary crystalline solid. Yield 46 %, 
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mp 158 °C, 1H NMR (D2O, 400 MHz): 
4.27 (1Н, dd, J = 7.5, 3.8, CHN), 3.98 
(1Н, dd, J = 15.2, 3.8, Нa in SCH2), 3.66 
(1Н, dd, J = 15.2, 7.5, Нb in SCH2), 3.21 
(6H, qv., J = 7.28, 3СН2), 1.29 (9H, t, J = 
7.28, 3CH3); 13C NMR (D2O, 100 MHz): 
172.02 (COO-), 166.09 (C2), 159.16 (C3a), 
144.55 (C7), 143.06 (C6), 54.47 (CHN), 
46.71 (3CH2), 31.67 (SCH2), 8.27 (3CH3); 
IR (ν/sm–1): 1682, 1615 (С=О); 1504, 1361 
(NO2); elemental analysis, calculated for 
С13H22N8O5S*Н2О, %: С 37.10, H 5.71, N 
26.63. Found, %: C 36.96, H 5.56, N 26.72.
2-(2’-Amino-ethylthio)-6-nitro-1,2,4-
triazolo[5,1-c]1,2,4-triazine hydrate (6) 
was obtained with use of the general 
methods 3 and 2 equivalent of trieth-
ylamine. The product was crystallized 
from the water ethanol in terms of canary 
crystalline solid. Yield 41 %, mp 285 °C, 
1H NMR (D2O, 400 MHz): 3.58 (2H, t, 
J = 7.03, NCH2), 3.49 (2H, t, J = 7.03, SCH2); 
13C NMR (DMSO-d6, 100 MHz): 163.95 
(C2), 160.12 (C3a), 144.77 (C7), 142.94 (C6), 
38.69 (CH2N), 27.87 (SCH2); IR (ν/sm-1): 
1690 (С=О); 1514, 1371 (NO2); 3521 
(broadened) (–NH3+); elemental analy-
sis, calculated for С6H7N7O3S*Н2О, %: 
С  26.18, H 3.27, N 35.64. Found, %: 
C 25.91, H 2.98, N 35
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